Immediate Impact
46 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Traditional Chinese medicine in lung cancer treatment
2025 Standout
Works of Mingjun Li being referenced
Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial.
2024
Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mingjun Li | 121 | 35 | 15 | 52 | 14 | 159 | |
| Minghe Li | 112 | 16 | 28 | 53 | 14 | 198 | |
| Weijie Zhou | 122 | 31 | 29 | 50 | 15 | 190 | |
| Yiming He | 151 | 21 | 16 | 111 | 14 | 202 | |
| Prabhakar Pitta Venkata | 125 | 33 | 20 | 46 | 15 | 225 | |
| Chengxuan Yu | 120 | 16 | 17 | 59 | 22 | 203 | |
| Huazhen Liang | 73 | 48 | 30 | 51 | 10 | 144 | |
| Fatemeh Alikarami | 103 | 32 | 12 | 23 | 14 | 173 | |
| Shibo Liu | 122 | 32 | 14 | 49 | 21 | 207 | |
| Haijuan Xiao | 134 | 50 | 40 | 90 | 15 | 230 | |
| Caishi Zhang | 65 | 43 | 24 | 30 | 11 | 149 |
All Works
Login with ORCID to disown or claim papers
Loading papers...